Glazer's Wholesale Drug Company, Inc. – Trademark Portfolio
Entity Type: 03
Glazer's Wholesale Drug Company, Inc. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 11 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GLAZER'S. The owner is based in Dallas, TX.
508 Park Ave.
Dallas, TX 75201
Showing of trademarks Trademarks
Trademark Classifications
Glazer's Wholesale Drug Company, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Frequently Asked Questions
How many trademarks does Glazer's Wholesale Drug Company, Inc. have?
Glazer's Wholesale Drug Company, Inc. has 13 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned, 8 cancelled.
What trademark classes does Glazer's Wholesale Drug Company, Inc. file in?
Glazer's Wholesale Drug Company, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 32 (Light Beverages). Class 35 covers advertising; business management; business administration; office functions.
What are Glazer's Wholesale Drug Company, Inc.'s most well-known trademarks?
Glazer's Wholesale Drug Company, Inc.'s registered trademark portfolio includes well-known marks such as GLAZER'S. These are among 1 currently registered trademark in the portfolio.
What is Glazer's Wholesale Drug Company, Inc.'s trademark registration success rate?
Glazer's Wholesale Drug Company, Inc. has a 8% trademark registration rate, with 1 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.